E
The startup develops therapeutics targeting glaucoma and diabetic retinopathy through a pipeline of drug candidates aimed at preventing vision loss. Their solutions focus on addressing the unmet medical needs in ophthalmic diseases to enhance patient outcomes and reduce the risk of blindness.
Updated 3 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Product
Features
- The startup develops therapeutics targeting glaucoma and diabetic retinopathy through a pipeline of drug candidates aimed at preventing vision loss. Their solutions focus on addressing the unmet medical needs in ophthalmic diseases to enhance patient outcomes and reduce the risk of blindness.